Top compounds associated with response to TCTA


Feature Type Standardized
Nominal ANOVA
mRNA Pazopanib FIMM pan-cancer AAC -0.054 0.8
mRNA valdecoxib CTRPv2 pan-cancer AAC -0.011 0.8
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.8
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC 0.015 0.8
mRNA lomeguatrib CTRPv2 pan-cancer AAC 0.011 0.8
mRNA VER-155008 CTRPv2 pan-cancer AAC 0.011 0.8
mRNA isoliquiritigenin CTRPv2 pan-cancer AAC 0.019 0.8
mRNA masitinib GDSC1000 pan-cancer AAC -0.0089 0.8
mRNA Rapamycin GDSC1000 pan-cancer AAC 0.014 0.8
mRNA I-BET151 CTRPv2 pan-cancer AAC 0.0089 0.8
Download CSV